For example, while all p-tau biomarkers relate to AD postmortem pathology6,14,15, in AD brain tissue, p-tau217 is prominently seen in granulovacuolar degeneration bodies and multivesicular bodies in neurons, which is not observed for p-tau181 and p-tau231 (ref. 23). This evidence concerns the gene MAPT and Alzheimer disease.